CurrentRheuma
Get Weekly

Topic · page 4 of 11

Inflammatory myopathies

Dermatomyositis, polymyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy, inclusion body myositis, myositis-specific antibodies, myositis-associated interstitial lung disease and cancer-associated myositis

Briefs 121–160 of 430 placed here, newest publication first

Briefs in Inflammatory myopathies

Newest publication first

  1. Clin Exp Rheumatol

    Cross-sectional analysis of quantitative computed tomography parameters and pulmonary function in anti-synthetase syndrome-associated interstitial lung disease

    Cohort study

  2. Semin Arthritis Rheum

    Performance of sit-to-stand, timed up-and-go, and six-minute walk tests in home and office settings in patients with idiopathic inflammatory myopathy

    Cohort study

  3. Rheumatology (Oxford)

    Anti-Mi2 autoantibodies target PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily bind TIF1γ outside the PHD region

    Mechanistic study

  4. Rheumatology (Oxford)

    Prevalence and functional characterization of anti-interferon autoantibodies in inflammatory myopathies

    Cross-sectional study

  5. Ann Rheum Dis

    HLA loci heterozygosity modulates genetic risk in idiopathic inflammatory myopathies

    Case-control study

  6. Clin Exp Rheumatol

    Janus kinase inhibitors therapy in idiopathic inflammatory myopathies: a case series

    Cohort study

  7. Clin Exp Rheumatol

    Long non-coding RNA expression profiles in neutrophils revealed potential biomarker for rapidly progressive interstitial lung disease in MDA5+ dermatomyositis

    Diagnostic or prognostic study

  8. Arthritis Care Res (Hoboken)

    Prevalence of Pain and Factors Associated With Pain in Patients With Idiopathic Inflammatory Myopathies

    Cross-sectional study

  9. Rheumatology (Oxford)

    Shared molecular profiles of anti-PL12 autoantibodies in anti-synthetase syndrome

    Mechanistic study

  10. Clin Exp Rheumatol

    Factors associated with endomysial fibrosis in anti-signal recognition particle antibody immune-mediated necrotising myopathy

    Cross-sectional study

  11. Clin Exp Rheumatol

    Alterations of mucosal-associated invariant T cells in dermatomyositis

    Cross-sectional study

  12. Arthritis Res Ther

    Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis

    Cross-sectional study

  13. Clin Exp Rheumatol

    Health-related quality of life improvements and response thresholds of myositis outcome measures and response criteria

    Cohort study

  14. Rheumatology (Oxford)

    Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis

    Cross-sectional study

  15. Clin Exp Rheumatol

    The Refractory DermatoMyositis Index (ReDMI): a clinical tool to predict refractory disease in patients with dermatomyositis

    Cohort study

  16. Clin Exp Rheumatol

    Validation of simplified scoring systems for assessing cutaneous disease activity in dermatomyositis

    Diagnostic or prognostic study

  17. Rheumatology (Oxford)

    Anti-HMGCR myopathy: observed ethnic differences in disease and disease outcomes in New Zealand

    Cohort study

  18. Clin Exp Rheumatol

    The MicroIBioM study: the gut microbiome in inclusion body myositis

    Case-control study

  19. RMD Open

    Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies

    Cohort study

  20. Rheumatology (Oxford)

    Predictive factors and clinical outcomes of progressive pulmonary fibrosis in anti-threonyl (PL7) positive anti-synthetase syndrome

    Cohort study

  21. Ann Rheum Dis

    Mitochondria-centred metabolomic map of inclusion body myositis: sex-specific alterations in central carbon metabolism

    Mechanistic study

  22. Rheumatology (Oxford)

    Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational study

    Cohort study

  23. Rheumatology (Oxford)

    Clinical-imaging characteristics and management of anti-JO-1 and non-JO-1 anti-synthetase syndrome–associated interstitial lung disease

    Cohort study

  24. Semin Arthritis Rheum

    Statin-associated immune-mediated necrotizing myopathy in Hispanic Americans

    Cohort study

  25. Arthritis Res Ther

    Clinicopathological profile of eosinophilic fasciitis: a retrospective cohort study from a neuromuscular disorder center in China

    Cohort study

  26. Rheumatology (Oxford)

    Efficacy and safety of ultrasound-guided needle muscle biopsy in the diagnosis of idiopathic inflammatory myopathies

    Cohort study

  27. Rheumatology (Oxford)

    The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study

    Cohort study

  28. Clin Exp Rheumatol

    Peripheral blood immunophenotypic diversity in patients with anti-MDA5+ dermatomyositis and its impact on prognosis

    Cohort study

  29. Arthritis Care Res (Hoboken)

    Racial, Ethnic, Sex, and Geographical Diversity in Myositis Clinical Trials

    Meta-analysis

  30. Rheumatology (Oxford)

    Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project

    Guideline or statement

  31. Rheumatology (Oxford)

    Short Form-36 psychometric properties in idiopathic inflammatory myopathies: reliability, validity and responsiveness

    Diagnostic or prognostic study

  32. Rheumatology (Oxford)

    Abatacept for the treatment of myositis-associated interstitial lung disease

    Randomized controlled trial

  33. Rheumatology (Oxford)

    Recruitment rate comparison between a virtual tele-research cohort and a traditional centre-based cohort in idiopathic inflammatory myopathy

    Cohort study

  34. Semin Arthritis Rheum

    Fatigue is common in myositis and is associated with disease activity

    Cohort study

  35. Ann Rheum Dis

    The Prospective Registry of MyositIS (PROMIS): I. Next-generation sequencing identifies HLA-DQA1 as a novel genetic risk of anti-MDA5 antibody-positive dermatomyositis

    Diagnostic or prognostic study

  36. Arthritis Res Ther

    Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis

    Diagnostic or prognostic study

  37. RMD Open

    CD73low B-cell phenotypes and distinct cytokine profiles in patients with active anti-Jo-1 antibody positive idiopathic inflammatory myopathies

    Mechanistic study

  38. Rheumatology (Oxford)

    Clinicopathological features of anti-HMGCR and anti-SRP myopathies that do not satisfy the EULAR/ACR criteria of inflammatory myopathies

    Cohort study

  39. Arthritis Res Ther

    Modulating IL-21-driven B cell responses in idiopathic inflammatory myopathies via inhibition of the JAK/STAT pathway

    Mechanistic study

  40. Clin Exp Rheumatol

    Prevalence and early detection of myocarditis in idiopathic inflammatory myopathies: a prospective single-centre study

    Cohort study

All 430 Briefs in ExploreShowing Briefs 121–160 of 430, newest first